nature.com search

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

Search
My Account Login

nature
search

Search

advanced

where the list of authors contains where the title contains

Refine your results by…

volume

start page / article no.

Filters

Filter By:

Article type

Check one or more article types to show results from those article types only.

Correspondence (4)
Research (4)
Reviews (1)

Journal

Check one or more journals to show results from those journals only.

Leukemia (8)
British Journal of Cancer (1)

Choose more journals

Subject Check one or more subjects to show results from those subjects only.

Genetics (5)
Diseases (5)
Cancer (2)
Pathogenesis (2)
Health care (2)
Biochemistry (1)
Biomarkers (1)
Biotechnology (1)
Medical research (1)
Biological techniques (1)

Date

Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
In the last year
Last 2 years
Last 5 years

Custom date range

Sort by Relevance

Choose a way to sort results.

Relevance
Date — most recent
Date — oldest first

Loading Filters

Showing 1–9 of 9 results

Loading Filters

Research | 22 January 2021
Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria
- Torsten-Haferlach Leukemia Diagnostics Foundation
- Carmelo Gurnari
- , Simona Pagliuca
- , Bhumika J. Patel
- , Hassan Awada
- , Sunisa Kongkiatkamon
- , Laila Terkawi
- , Misam Zawit
- , Seth Corey
- , Alan E. Lichtin
- , Hetty E. Carraway
- , Adam Wahida
- , Valeria Visconte
- & Jaroslaw P. Maciejewski
Leukemia , 1–4

Rights & permissionsfor article Implication of <i>PIGA</i> genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria . Opens in a new window.
Research | 6 March 2018
Minimal residual disease (MRD) monitoring and mutational landscape in AML with RUNX1-RUNX1T1: a study on 134 patients
- torsten.haferlach@mll.com
Leukemia 32 , 2270–2274

Rights & permissionsfor article Minimal residual disease (MRD) monitoring and mutational landscape in AML with <i>RUNX1</i>-<i>RUNX1T1</i>: a study on 134 patients . Opens in a new window.
Correspondence | 25 May 2016
Robustness of comprehensive DNA- and RNA-based assays at diagnosis of acute myeloid leukemia using blood and bone marrow stored on filter cards
- torsten.haferlach@mll.com
- T Haferlach
- , S Weber
- , R Konietschke
- , N Nadarajah
- , A Stengel
- , W Kern
- , C Haferlach
- & M Meggendorfer
Leukemia 30 , 2123–2125

Rights & permissionsfor article Robustness of comprehensive DNA- and RNA-based assays at diagnosis of acute myeloid leukemia using blood and bone marrow stored on filter cards . Opens in a new window.
Research | 13 November 2013 | Open
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
- torsten.haferlach@mll.com
- T Haferlach
- , Y Nagata
- , V Grossmann
- , Y Okuno
- , U Bacher
- , G Nagae
- , S Schnittger
- , M Sanada
- , A Kon
- , T Alpermann
- , K Yoshida
- , A Roller
- , N Nadarajah
- , Y Shiraishi
- , Y Shiozawa
- , K Chiba
- , H Tanaka
- , H P Koeffler
- , H-U Klein
- , M Dugas
- , H Aburatani
- , A Kohlmann
- , S Miyano
- , C Haferlach
- , W Kern
- & S Ogawa
Leukemia 28 , 241–247

Rights & permissionsfor article Landscape of genetic lesions in 944 patients with myelodysplastic syndromes . Opens in a new window.
Research | 5 February 2009
AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features
- torsten.haferlach@mll-online.com
- T Haferlach
- , A Kohlmann
- , H-U Klein
- , C Ruckert
- , M Dugas
- , P M Williams
- , W Kern
- , S Schnittger
- , U Bacher
- , H Löffler
- & C Haferlach
Leukemia 23 , 934–943

Rights & permissionsfor article AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features . Opens in a new window.
Reviews | 5 December 2006 | Open
Gene expression profiling for the diagnosis of acute leukaemia
- torsten.haferlach@mll-online.com
- T Haferlach
- , A Kohlmann
- , U Bacher
- , S Schnittger
- , C Haferlach
- & W Kern
British Journal of Cancer 96 , 535–540

Rights & permissionsfor article Gene expression profiling for the diagnosis of acute leukaemia . Opens in a new window.
Correspondence | 23 May 2016 | Open
The new provisional WHO entity ‘RUNX1 mutated AML’ shows specific genetics but no prognostic influence of dysplasia
- torsten.haferlach@mll.com
- T Haferlach
- , A Stengel
- , S Eckstein
- , K Perglerová
- , T Alpermann
- , W Kern
- , C Haferlach
- & M Meggendorfer
Leukemia 30 , 2109–2112

Rights & permissionsfor article The new provisional WHO entity ‘<i>RUNX1</i> mutated AML’ shows specific genetics but no prognostic influence of dysplasia . Opens in a new window.
Correspondence | 7 May 2013
Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics
- torsten.haferlach@mll.com
- V Grossmann
- , U Bacher
- , C Haferlach
- , S Schnittger
- , F Pötzinger
- , S Weissmann
- , A Roller
- , C Eder
- , A Fasan
- , M Zenger
- , M Staller
- , W Kern
- , A Kohlmann
- & T Haferlach
Leukemia 27 , 1940–1943

Rights & permissionsfor article Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics . Opens in a new window.
Correspondence | 15 April 2011
Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics
- torsten.haferlach@mll.com
- U Bacher
- , W Kern
- , T Alpermann
- , S Schnittger
- , A Kohlmann
- , H-U Klein
- , M Dugas
- , C Haferlach
- & T Haferlach
Leukemia 25 , 1361–1364

Rights & permissionsfor article Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics . Opens in a new window.

Advertisement

Search

Search articles by keyword or author

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

nature.com sitemap

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
Nano
Protocol Exchange
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Nature Research Academies

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Career development

Nature Careers
Nature Conferences
Nature events

Regional websites

Nature China
Nature India
Nature Japan
Nature Korea
Nature Middle East

Legal & Privacy

Privacy Policy
Use of cookies
Manage cookies/Do not sell my data
Legal notice
Accessibility statement
Terms & Conditions
California Privacy Statement

© 2021 Springer Nature Limited